The table below shows AbbVie Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$61.16B
$56.33B
$54.32B
$58.05B
$56.20B
$45.80B
Cost of revenue
$18.20B
$16.90B
$20.41B
$17.41B
$17.45B
$15.39B
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
ABBV annual revenue (10-K history)
AbbVie Inc. reported annual revenue of $61.16B for fiscal year 2025. That is up 8.6% from $56.33B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $25.64B (FY 2016) to $61.16B. Figures come from the company's audited annual reports as filed with the SEC.
